Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC944428555;28556;28557 chr2:178710767;178710766;178710765chr2:179575494;179575493;179575492
N2AB912727604;27605;27606 chr2:178710767;178710766;178710765chr2:179575494;179575493;179575492
N2A820024823;24824;24825 chr2:178710767;178710766;178710765chr2:179575494;179575493;179575492
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAG
  • RefSeq wild type template codon: GTC
  • Domain: Ig-80
  • Domain position: 48
  • Structural Position: 122
  • Q(SASA): 0.4471
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/R None None 0.27 None 0.3 0.165 0.229924730088 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.2915 likely_benign 0.382 ambiguous -0.568 Destabilizing 0.495 N 0.375 neutral None None None None I
Q/C 0.689 likely_pathogenic 0.8163 pathogenic 0.06 Stabilizing 0.995 D 0.45 neutral None None None None I
Q/D 0.4551 ambiguous 0.5309 ambiguous 0.093 Stabilizing 0.329 N 0.271 neutral None None None None I
Q/E 0.1184 likely_benign 0.1093 benign 0.126 Stabilizing 0.27 N 0.267 neutral None None None None I
Q/F 0.7008 likely_pathogenic 0.8116 pathogenic -0.524 Destabilizing 0.981 D 0.446 neutral None None None None I
Q/G 0.3702 ambiguous 0.4754 ambiguous -0.837 Destabilizing 0.003 N 0.286 neutral None None None None I
Q/H 0.1807 likely_benign 0.2442 benign -0.731 Destabilizing 0.927 D 0.38 neutral None None None None I
Q/I 0.3733 ambiguous 0.4585 ambiguous 0.08 Stabilizing 0.944 D 0.437 neutral None None None None I
Q/K 0.0874 likely_benign 0.0963 benign 0.015 Stabilizing 0.001 N 0.147 neutral None None None None I
Q/L 0.1635 likely_benign 0.2084 benign 0.08 Stabilizing 0.642 D 0.423 neutral None None None None I
Q/M 0.3842 ambiguous 0.4799 ambiguous 0.511 Stabilizing 0.981 D 0.387 neutral None None None None I
Q/N 0.2825 likely_benign 0.38 ambiguous -0.434 Destabilizing 0.031 N 0.128 neutral None None None None I
Q/P 0.6551 likely_pathogenic 0.7561 pathogenic -0.107 Destabilizing 0.784 D 0.455 neutral None None None None I
Q/R 0.0859 likely_benign 0.1067 benign 0.09 Stabilizing 0.27 N 0.3 neutral None None None None I
Q/S 0.2603 likely_benign 0.3878 ambiguous -0.558 Destabilizing 0.495 N 0.27 neutral None None None None I
Q/T 0.1961 likely_benign 0.2651 benign -0.338 Destabilizing 0.704 D 0.389 neutral None None None None I
Q/V 0.2689 likely_benign 0.3423 ambiguous -0.107 Destabilizing 0.828 D 0.434 neutral None None None None I
Q/W 0.5825 likely_pathogenic 0.7053 pathogenic -0.362 Destabilizing 0.995 D 0.454 neutral None None None None I
Q/Y 0.479 ambiguous 0.6198 pathogenic -0.145 Destabilizing 0.981 D 0.423 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.